Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
The net profit margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
NET PROFIT MARGIN
0.00%
NET PROFIT MARGIN AVG TTM
0.00%
NET PROFIT MARGIN AVG 3Y
0.00%
NET PROFIT MARGIN AVG 5Y
0.00%
NET PROFIT MARGIN AVG 10Y
-114.01%
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
+100.00%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 511 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Aptevo Therapeutics Inc.
Market Cap
$3.98M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$4.29M
Net Profit Margin
-285.00%
TTM Avg
-249.81%
3Y Avg
-232.15%
5Y Avg
-165.63%
Market Cap
$4.40M
Net Profit Margin
-3934.91%
TTM Avg
-1854.81%
3Y Avg
-2358.55%
5Y Avg
-1587.79%
Market Cap
$4.49M
Net Profit Margin
0.00%
TTM Avg
-3826.38%
3Y Avg
-9879.36%
5Y Avg
-6586.24%
Market Cap
$4.50M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$3.39M
Net Profit Margin
-694.19%
TTM Avg
-257.90%
3Y Avg
-726.73%
5Y Avg
-1357.15%
Market Cap
$3.37M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Aptevo Therapeutics Inc. (APVO) | $3.98M | 0.00% | 0.00% | 0.00% | 0.00% |
| GRI Bio, Inc. (GRI)vs › | $4.18M | N/A | 0.00% | 0.00% | -421.83% |
| 20/20 Biolabs Inc. (AIDX)vs › | $4.29M | -285.00% | -249.81% | -232.15% | -165.63% |
| Eocene Ltd. (EOCN)vs › | $3.59M | N/A | N/A | N/A | N/A |
| CollPlant Biotechnologies Ltd. (CLGN)vs › | $4.40M | -3934.91% | -1854.81% | -2358.55% | -1587.79% |
| Ernexa Therapeutics Inc. (ERNA)vs › | $4.49M | 0.00% | -3826.38% | -9879.36% | -6586.24% |
| Dermata Therapeutics, Inc. (DRMA)vs › | $4.50M | 0.00% | 0.00% | 0.00% | 0.00% |
| Evogene Ltd. (EVGN)vs › | $3.39M | -694.19% | -257.90% | -726.73% | -1357.15% |
| Cadrenal Therapeutics, Inc. Common Stock (CVKD)vs › | $3.37M | 0.00% | 0.00% | 0.00% | 0.00% |
| IceCure Medical Ltd (ICCM)vs › | $3.36M | -427.67% | -455.53% | -478.79% | -375.12% |
Operating Margin
0.0%
Net Profit Margin
0.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | -247.17% |
| 2021-12-31 | -171.13% |
| 2021-09-30 | -226.00% |
| 2021-06-30 | -255.05% |
| 2021-03-31 | -299.71% |
| 2020-12-31 | -297.22% |
| 2020-09-30 | -464.18% |
| 2020-06-30 | -1438.27% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | -90.51% |
| 2019-09-30 | -76.84% |
| 2019-06-30 | -181.14% |
| 2019-03-31 | -171.15% |
| 2018-12-31 | -222.63% |
| 2018-09-30 | -215.69% |
| 2018-06-30 | -192.56% |
| 2018-03-31 | -340.31% |
| 2017-12-31 | -346.34% |
| 2017-09-30 | 613.53% |
| 2017-06-30 | -103.95% |
| 2017-03-31 | -134.23% |
| 2016-12-31 | -170.44% |
| 2016-09-30 | -762.80% |
| 2016-06-30 | -125.95% |
| 2016-03-31 | -146.63% |
| 2015-12-31 | -216.00% |
| 2015-09-30 | -193.23% |
| 2015-06-30 | -249.87% |
| 2015-03-31 | -94.50% |
